(3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide

C148H181N15O20 — CID 162067890

About (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide

(3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide (PubChem CID 162067890) has the molecular formula C148H181N15O20 and a molecular weight of 2490.16 g/mol. Its IUPAC name is (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide.

Molecular Properties

• Compound Name: (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide
• PubChem CID: 162067890
• Molecular Formula: C148H181N15O20
• Molecular Weight: 2490.16 g/mol
• Exact Mass: 2488.36
• IUPAC Name: (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide
• SMILES: C[C@@H](O)[C@H]1[C@@H](CO)ON(Cc2cccc(C#CCNC(=O)NC3CC3c3ccccc3)c2)[C@H]1C(=O)NCCCN(C)c1ccccc1.C[C@@H](O)[C@H]1[C@@H](CO)ON(Cc2cccc(C#CCNCc3ccccc3)c2)[C@H]1C(=O)NCCCN(C)c1ccccc1.C[C@@H](O)[C@H]1[C@@H](CO)ON(Cc2cccc(C#C[C@@H](O)c3ccccc3)c2)[C@H]1C(=O)NCCCN(C)c1ccccc1.C[C@H](O)[C@@H]1[C@H](CO)ON(Cc2cccc(C#C[C@]3(O)CCC4[C@@H]5CCc6ccc(O)cc6[C@H]5CC[C@@]43C)c2)[C@@H]1C(=O)NCCCN(C)c1ccccc1
• InChI: InChI=1S/C44H55N3O6.C37H45N5O5.C34H42N4O4.C33H39N3O5/c1-29(49)40-39(28-48)53-47(41(40)42(51)45-23-8-24-46(3)33-11-5-4-6-12-33)27-31-10-7-9-30(25-31)17-21-44(52)22-19-38-36-16-14-32-13-15-34(50)26-37(32)35(36)18-20-43(38,44)2;1-26(44)34-33(25-43)47-42(35(34)36(45)38-20-11-21-41(2)30-17-7-4-8-18-30)24-28-13-9-12-27(22-28)14-10-19-39-37(46)40-32-23-31(32)29-15-5-3-6-16-29;1-26(40)32-31(25-39)42-38(33(32)34(41)36-20-11-21-37(2)30-17-7-4-8-18-30)24-29-15-9-14-27(22-29)16-10-19-35-23-28-12-5-3-6-13-28;1-24(38)31-30(23-37)41-36(32(31)33(40)34-19-10-20-35(2)28-15-7-4-8-16-28)22-26-12-9-11-25(21-26)17-18-29(39)27-13-5-3-6-14-27/h4-7,9-13,15,25-26,29,35-36,38-41,48-50,52H,8,14,16,18-20,22-24,27-28H2,1-3H3,(H,45,51);3-9,12-13,15-18,22,26,31-35,43-44H,11,19-21,23-25H2,1-2H3,(H,38,45)(H2,39,40,46);3-9,12-15,17-18,22,26,31-33,35,39-40H,11,19-21,23-25H2,1-2H3,(H,36,41);3-9,11-16,21,24,29-32,37-39H,10,19-20,22-23H2,1-2H3,(H,34,40)/t29-,35-,36+,38?,39-,40+,41-,43-,44-;26-,31?,32?,33-,34+,35-;26-,31-,32+,33-;24-,29-,30-,31+,32-/m0111/s1
• InChIKey: ZAROYWXRUGXNRM-HCFSLGSOSA-N
• XLogP: 13.99
• TPSA: 454.93 Ų
• H-Bond Donors: 18
• H-Bond Acceptors: 29
• Rotatable Bonds: 47
• Heavy Atoms: 183
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2490.16
LogP ≤ 5	13.99
H-Bond Donors ≤ 5	18
H-Bond Acceptors ≤ 10	29

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide?

The IUPAC name of (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide (CID 162067890) is (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide.

What is the SMILES notation for (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide?

The canonical SMILES for (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide is C[C@@H](O)[C@H]1[C@@H](CO)ON(Cc2cccc(C#CCNC(=O)NC3CC3c3ccccc3)c2)[C@H]1C(=O)NCCCN(C)c1ccccc1.C[C@@H](O)[C@H]1[C@@H](CO)ON(Cc2cccc(C#CCNCc3ccccc3)c2)[C@H]1C(=O)NCCCN(C)c1ccccc1.C[C@@H](O)[C@H]1[C@@H](CO)ON(Cc2cccc(C#C[C@@H](O)c3ccccc3)c2)[C@H]1C(=O)NCCCN(C)c1ccccc1.C[C@H](O)[C@@H]1[C@H](CO)ON(Cc2cccc(C#C[C@]3(O)CCC4[C@@H]5CCc6ccc(O)cc6[C@H]5CC[C@@]43C)c2)[C@@H]1C(=O)NCCCN(C)c1ccccc1.

What is the InChIKey of (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide?

The InChIKey is ZAROYWXRUGXNRM-HCFSLGSOSA-N. The full InChI is InChI=1S/C44H55N3O6.C37H45N5O5.C34H42N4O4.C33H39N3O5/c1-29(49)40-39(28-48)53-47(41(40)42(51)45-23-8-24-46(3)33-11-5-4-6-12-33)27-31-10-7-9-30(25-31)17-21-44(52)22-19-38-36-16-14-32-13-15-34(50)26-37(32)35(36)18-20-43(38,44)2;1-26(44)34-33(25-43)47-42(35(34)36(45)38-20-11-21-41(2)30-17-7-4-8-18-30)24-28-13-9-12-27(22-28)14-10-19-39-37(46)40-32-23-31(32)29-15-5-3-6-16-29;1-26(40)32-31(25-39)42-38(33(32)34(41)36-20-11-21-37(2)30-17-7-4-8-18-30)24-29-15-9-14-27(22-29)16-10-19-35-23-28-12-5-3-6-13-28;1-24(38)31-30(23-37)41-36(32(31)33(40)34-19-10-20-35(2)28-15-7-4-8-16-28)22-26-12-9-11-25(21-26)17-18-29(39)27-13-5-3-6-14-27/h4-7,9-13,15,25-26,29,35-36,38-41,48-50,52H,8,14,16,18-20,22-24,27-28H2,1-3H3,(H,45,51);3-9,12-13,15-18,22,26,31-35,43-44H,11,19-21,23-25H2,1-2H3,(H,38,45)(H2,39,40,46);3-9,12-15,17-18,22,26,31-33,35,39-40H,11,19-21,23-25H2,1-2H3,(H,36,41);3-9,11-16,21,24,29-32,37-39H,10,19-20,22-23H2,1-2H3,(H,34,40)/t29-,35-,36+,38?,39-,40+,41-,43-,44-;26-,31?,32?,33-,34+,35-;26-,31-,32+,33-;24-,29-,30-,31+,32-/m0111/s1.

What are the key properties of (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide?

(3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide has a molecular weight of 2490.16 g/mol, XLogP of 13.99, 47 rotatable bonds, 18 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for (3R,4S,5S)-2-[[3-[3-(benzylamino)prop-1-ynyl]phenyl]methyl]-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3S,4R,5R)-2-[[3-[2-[(8R,9S,13S,17S)-2,17-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethynyl]phenyl]methyl]-4-[(1S)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-2-[[3-[(3S)-3-hydroxy-3-phenylprop-1-ynyl]phenyl]methyl]-N-[3-(N-methylanilino)propyl]-1,2-oxazolidine-3-carboxamide;(3R,4S,5S)-4-[(1R)-1-hydroxyethyl]-5-(hydroxymethyl)-N-[3-(N-methylanilino)propyl]-2-[[3-[3-[(2-phenylcyclopropyl)carbamoylamino]prop-1-ynyl]phenyl]methyl]-1,2-oxazolidine-3-carboxamide is sourced from PubChem (CID 162067890), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).